id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
NRC-2008-0175-0070,NRC,NRC-2008-0175,"Summary of February 12, 2015, Public Meeting Between Spectrum Pharmaceuticals, Inc., and the NRC Regarding Modification of the Training and Experience Requirements for  Beta Emitter Products",Other,,2015-03-11T00:00:00Z,2015,3,2015-03-11T00:00:00Z,,2025-05-21T07:30:01Z,,0,0,0900006481a3b31d
NRC-2008-0175-0068,NRC,NRC-2008-0175,"Summary of October 8, 2014, Meeting",Other,,2015-03-11T00:00:00Z,2015,3,2015-03-11T00:00:00Z,,2025-05-21T07:30:02Z,,0,0,0900006481a3b725
NRC-2008-0175-0069,NRC,NRC-2008-0175,"Transcript of October 8, 2014, Meeting",Other,,2015-03-11T00:00:00Z,2015,3,2015-03-11T00:00:00Z,,2025-05-21T07:30:02Z,,0,0,0900006481a3b726